litlas
ログインアカウント作成

Miquel Vila

1996–2025 年に発表

別表記
Miquel Vilà
90
論文数
20,726
被引用数
69
h 指数
88
i10 指数

被引用数

Miquel Vila の年別被引用数1990 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 11 件1998 年: 被引用 22 件1999 年: 被引用 18 件2000 年: 被引用 48 件2001 年: 被引用 84 件2002 年: 被引用 132 件2003 年: 被引用 245 件2004 年: 被引用 306 件2005 年: 被引用 300 件2006 年: 被引用 277 件2007 年: 被引用 261 件2008 年: 被引用 275 件2009 年: 被引用 269 件2010 年: 被引用 241 件2011 年: 被引用 286 件2012 年: 被引用 234 件2013 年: 被引用 269 件2014 年: 被引用 260 件2015 年: 被引用 291 件2016 年: 被引用 257 件2017 年: 被引用 273 件2018 年: 被引用 296 件2019 年: 被引用 667 件2020 年: 被引用 744 件2021 年: 被引用 789 件2022 年: 被引用 706 件2023 年: 被引用 513 件2024 年: 被引用 662 件2025 年: 被引用 377 件2026 年: 被引用 8 件1991〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,569 件、この内訳の 24.6%中国: 引用元論文 1,121 件、この内訳の 10.7%イギリス: 引用元論文 636 件、この内訳の 6.1%ドイツ: 引用元論文 543 件、この内訳の 5.2%イタリア: 引用元論文 494 件、この内訳の 4.7%スペイン: 引用元論文 459 件、この内訳の 4.4%フランス: 引用元論文 410 件、この内訳の 3.9%インド: 引用元論文 361 件、この内訳の 3.5%カナダ: 引用元論文 342 件、この内訳の 3.3%日本: 引用元論文 304 件、この内訳の 2.9%韓国: 引用元論文 291 件、この内訳の 2.8%オーストラリア: 引用元論文 245 件、この内訳の 2.3%
0%24.6%その他 25.6%

機関

分野

  • Medicine56.2%
  • Biochemistry, Genetics and Molecular Biology21.5%
  • Neuroscience16.5%
  • Immunology and Microbiology1.2%
  • Materials Science0.7%
  • Chemistry0.6%
  • その他3.3%

トピック

  • Parkinson's Disease Mechanisms and Treatments15.1%
  • Neuroinflammation and Neurodegeneration Mechanisms5.3%
  • Alzheimer's disease research and treatments4.6%
  • Neurological disorders and treatments4%
  • Autophagy in Disease and Therapy3.9%
  • Nuclear Receptors and Signaling3.7%
  • その他63.4%

共著者

全論文

検索で開く
  1. LRRK2 in Parkinson disease: challenges of clinical trials

    著者: Eduardo Tolosa, Miquel Vila, Christine Klein, Olivier Rascol - Nature Reviews Neurology 2020 被引用: 455

  2. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson’s disease

    著者: Jordi Galiano-Landeira, Albert Torra, Miquel Vila, Jordi Bové - Brain 2020 被引用: 280

  3. Pathogenic Lysosomal Depletion in Parkinson's Disease

    著者: Benjamin Dehay, Jordi Bové, Natalia Rodríguez‐Muela, Céline Perier, Ariadna Recasens, Patricia Boya, Miquel Vila - Journal of Neuroscience 2010 被引用: 804

  4. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

    著者: Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, Serge Przedborski, Miquel Vila, Stéphane Hunot, Andrew Singleton, C. Warren Olanow, Kalpana Merchant, Erwan Bézard, Gregory A. Petsko, Wassilios G. Meissner - The Lancet Neurology 2015 被引用: 509

  5. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease

    著者: Emma Biondetti, Mathieu Santin, Romain Valabrègue, Graziella Mangone, Rahul Gaurav, Nadya Pyatigorskaya, Matthew Hutchison, Lydia Yahia‐Cherif, Nicolas Villain, Marie‐Odile Habert, Isabelle Arnulf, Smaranda Leu‐Semenescu, Pauline Dodet, Miquel Vila, Jean‐Christophe Corvol, Marie Vidailhet, Stéphane Lehéricy - Brain 2021 被引用: 174

  6. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis

    著者: Iria Carballo‐Carbajal, Ariadna Laguna, Jordi Romero‐Giménez, Thaïs Cuadros, Jordi Bové, Marta Martínez‐Vicente, Annabelle Parent, Marta González-Sepúlveda, Núria Peñuelas, Albert Torra, Beatriz Rodríguez-Galván, Andrea Ballabio, Takafumi Hasegawa, Analı́a Bortolozzi, Ellen Gelpí, Miquel Vila - Nature Communications 2019 被引用: 339

  7. Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease

    著者: Sandra Franco-Iborra, Ainhoa Plaza‐Zabala, Marta Montpeyó, David Sebastián, Miquel Vila, Marta Martínez‐Vicente - Autophagy 2020 被引用: 197

  8. Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

    著者: Ariadna Recasens, Benjamin Dehay, Jordi Bové, Iria Carballo‐Carbajal, Sandra Doveró, Ana Pérez‐Villalba, Pierre‐Olivier Fernagut, Javier Blesa, Annabelle Parent, Céline Perier, Isabel Fariñas, José Á. Obeso, Erwan Bézard, Miquel Vila - Annals of Neurology 2013 被引用: 631

  9. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

    著者: Marie-Laure Arotçarena, Sandra Doveró, Alice Prigent, Mathieu Bourdenx, Sandrine Camus, Grégory Porras, Marie-Laure Thiolat, Maddalena Tasselli, Philippe Aubert, Niels Kruse, Brit Mollenhauer, Inés Trigo‐Damas, Cristina Estrada, Nuria García‐Carrillo, Nishant N. Vaikath, Omar M. A. El‐Agnaf, María Trinidad Herrero, Miquel Vila, José Á. Obeso, Pascal Derkinderen, Benjamin Dehay, Erwan Bézard - Brain 2020 被引用: 208

  10. Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology

    著者: Alba Navarro-Romero, Irene Fernández-González, Jordi Riera, Marta Montpeyó, Merce Albert-Bayo, Tresa López‐Royo, Pablo Castillo-Sanchez, Clara Carnicer-Cáceres, Jose Antonio Arranz-Amo, Laura Castillo‐Ribelles, Eddie Pradas, Josefina Casas, Miquel Vila, Marta Martínez‐Vicente - npj Parkinson s Disease 2022 被引用: 86

  11. Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease

    著者: Miquel Vila - Movement Disorders 2019 被引用: 151

  12. Fighting neurodegeneration with rapamycin: mechanistic insights

    著者: Jordi Bové, Marta Martínez‐Vicente, Miquel Vila - Nature reviews. Neuroscience 2011 被引用: 539

  13. Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson’s Disease

    著者: Diana Alarcón-Arís, Ariadna Recasens, Mireia Galofré, Iria Carballo‐Carbajal, Nicolás Zacchi, Esther Ruiz‐Bronchal, Rubén Pavia-Collado, Rosario Chica, Albert Ferrés‐Coy, Marina Santos, Raquel Revilla, Andrés Montefeltro, Isabel Fariñas, Francesc Artigas, Miquel Vila, Analı́a Bortolozzi - Molecular Therapy 2017 被引用: 136

  14. Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy

    著者: Lluís Miquel-Rio, Diana Alarcón-Arís, María Torres‐López, Valentín Cóppola-Segovia, Rubén Pavia-Collado, Verónica Paz, Esther Ruiz‐Bronchal, Leticia Campa, Carmen Casal, Andrés Montefeltro, Miquel Vila, Francesc Artigas, Raquel Revilla, Analı́a Bortolozzi - Translational Psychiatry 2022 被引用: 53

  15. Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration

    著者: Benjamin Dehay, Alfredo Ramı́rez, Marta Martínez‐Vicente, Céline Perier, Marie‐Hélène Canron, Évelyne Doudnikoff, Anne Vital, Miquel Vila, Christine Klein, Erwan Bézard - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 372

  16. Lysosomal impairment in Parkinson's disease

    著者: Benjamin Dehay, Marta Martínez‐Vicente, Guy A. Caldwell, Kim A. Caldwell, Zhenyue Yue, Mark Cookson, Christine Klein, Miquel Vila, Erwan Bézard - Movement Disorders 2013 被引用: 333

  17. Mitochondrial Biology and Parkinson's Disease

    著者: Céline Perier, Miquel Vila - Cold Spring Harbor Perspectives in Medicine 2011 被引用: 309

  18. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

    著者: Du‐Chu Wu, Peter Teismann, Kim Tieu, Miquel Vila, Vernice Jackson‐Lewis, Harry Ischiropoulos, Serge Przedborski - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 628

  19. D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

    著者: Kim Tieu, Céline Perier, Casper Caspersen, Peter Teismann, Du‐Chu Wu, Shi-Du Yan, Ali Naini, Miquel Vila, Vernice Jackson‐Lewis, Ravichandran Ramasamy, Serge Przedborski - Journal of Clinical Investigation 2003 被引用: 412

  20. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys

    著者: Diana Alarcón-Arís, Rubén Pavia-Collado, Lluís Miquel-Rio, Valentín Cóppola-Segovia, Albert Ferrés‐Coy, Esther Ruiz‐Bronchal, Mireia Galofré, Verónica Paz, Leticia Campa, Raquel Revilla, Andrés Montefeltro, Jeffrey H. Kordower, Miquel Vila, Francesc Artigas, Analı́a Bortolozzi - EBioMedicine 2020 被引用: 77

  21. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

    著者: Peter Teismann, Kim Tieu, Dong‐Kug Choi, Du‐Chu Wu, Ali Naini, Stéphane Hunot, Miquel Vila, Vernice Jackson‐Lewis, Serge Przedborski - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 659

  22. Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease

    著者: Adriana Sánchez‐Danés, Yvonne Richaud‐Patín, Iria Carballo‐Carbajal, Senda Jiménez‐Delgado, Carles Caig, Sergio Mora, Claudia Di Guglielmo, Mario Ezquerra, Bindiben Patel, Albert Giralt, Josep M. Canals, Maurizio Memo, Jordi Alberch, José López‐Barneo, Miquel Vila, Ana María Cuervo, Eduard Tolosa, Antonella Consiglio, Ángel Raya - EMBO Molecular Medicine 2012 被引用: 565

  23. Series Introduction: Neurodegeneration: What is it and where are we?

    著者: Serge Przedborski, Miquel Vila, Vernice Jackson‐Lewis - Journal of Clinical Investigation 2003 被引用: 457

  24. Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

    著者: Sandra Franco-Iborra, Miquel Vila, Céline Perier - Frontiers in Neuroscience 2018 被引用: 200